|
|
|
Insider
Information: |
Patel Sanj K |
Relationship: |
|
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
63,012 |
|
Indirect Shares
|
109,795 |
|
|
Direct
Value |
$1,214,241 |
|
|
Indirect Value
|
$2,115,750 |
|
|
Total
Shares |
172,807 |
|
|
Total
Value |
$3,329,991 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synageva BioPharma Corp |
GEVA |
President & CEO, Direc... |
2015-06-22 |
0 |
2015-06-22 |
0 |
Premium* |
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-08 |
63,012 |
2024-04-08 |
109,795 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2015-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
72,000 |
73,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2015-06-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(73,031) |
0 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2015-06-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(286) |
0 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2018-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
135,889 |
245,685 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2020-03-06 |
4 |
AS |
$20.00 |
$662,300 |
I/I |
(33,115) |
212,570 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2020-10-09 |
4 |
AS |
$21.00 |
$14,070 |
I/I |
(670) |
211,900 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2020-10-09 |
4 |
AS |
$21.00 |
$18,312 |
D/D |
(872) |
0 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2020-10-09 |
4 |
OE |
$1.59 |
$1,386 |
D/D |
872 |
872 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2020-10-12 |
4 |
OE |
$1.59 |
$239,613 |
D/D |
150,700 |
150,700 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2020-10-12 |
4 |
AS |
$21.02 |
$3,167,714 |
D/D |
(150,700) |
0 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2020-10-12 |
4 |
AS |
$21.02 |
$2,087,917 |
I/I |
(99,330) |
112,570 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2021-02-08 |
4 |
AS |
$23.00 |
$104,144 |
I/I |
(4,528) |
108,042 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2021-02-08 |
4 |
AS |
$23.00 |
$113,252 |
D/D |
(4,924) |
0 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2021-02-08 |
4 |
OE |
$1.59 |
$7,829 |
D/D |
4,924 |
4,924 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2021-02-09 |
4 |
OE |
$1.59 |
$32,438 |
D/D |
20,401 |
20,401 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2021-02-09 |
4 |
AS |
$23.04 |
$470,039 |
D/D |
(20,401) |
0 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2021-02-09 |
4 |
AS |
$23.08 |
$543,973 |
I/I |
(23,569) |
84,473 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2021-02-10 |
4 |
AS |
$23.07 |
$26,231 |
I/I |
(1,137) |
83,336 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2021-02-10 |
4 |
AS |
$23.06 |
$36,896 |
D/D |
(1,600) |
0 |
0 |
% |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2021-02-10 |
4 |
OE |
$1.59 |
$2,544 |
D/D |
1,600 |
1,600 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2022-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,569 |
6,569 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
|
2022-03-16 |
4 |
D |
$10.13 |
$19,470 |
D/D |
(1,922) |
4,647 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2022-03-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,555 |
23,202 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2022-03-21 |
4 |
D |
$10.98 |
$59,797 |
D/D |
(5,446) |
17,756 |
0 |
- |
|
KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
|
2022-09-02 |
4 |
D |
$11.44 |
$22,068 |
D/D |
(1,929) |
22,396 |
0 |
- |
|
93 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|